Relationship of c-erbB-2 expression to clinicopathological features and prognosis in gastric cancer

被引：0
|
作者：
Karayiannakis, AJ [1 ]
Syrigos, KN [1 ]
Chatzigianni, E [1 ]
Valinos, P [1 ]
Bousiakos, P [1 ]
Balas, G [1 ]
Lakiotis, G [1 ]
Simatos, G [1 ]
机构：
[1] IKA Hosp 1, Dept Surg 1, Athens, Greece
来源：
3RD INTERNATIONAL GASTRIC CANCER CONGRESS | 1999年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this study, the expression of c-erbB-2 was investigated immunohistochemically in 61 formalin-fixed, paraffin-embedded specimens of gastric carcinoma. Membranous c-erbB-2 immunoreactivity was observed in 36% of tumours. Intestinal type tumours had a significantly higher incidence of c-erbB-2 expression than did diffuse type tumours. c-erbB-2 expression correlated with serosal invasion, lymph node metastasis and advanced tumour stage compared with c-erbB-2 negative tumours. Survival rates of patients with c-erbB-2 positive carcinomas were significantly lower than those with c-erbB-2 negative carcinomas. These findings suggest that erbB-2 expression is associated with an aggressive phenotype and poor prognosis in gastric cancer.
引用
收藏
页码：269 / 272
页数：4
相关论文
共 50 条
  • [31] The association of HOTAIR expression with clinicopathological features and prognosis in gastric cancer patients
    Liu, Fang-Teng
    Qiu, Cheng
    Luo, Hong-Liang
    Zhang, Yi
    Xia, Guang-Feng
    Hao, Teng-Fei
    Zhu, Pei-Qian
    PANMINERVA MEDICA, 2016, 58 (02) : 167 - 174
  • [32] Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of vater
    Ajiki, T
    Kamigaki, T
    Hasegawa, Y
    Fujino, Y
    Suzuki, Y
    Takeyama, Y
    Ku, Y
    Kuroda, Y
    HEPATO-GASTROENTEROLOGY, 2001, 48 (41) : 1266 - 1270
  • [33] EXPRESSION AND SIGNIFICANCE OF C-erbB-2 IN THE TISSUES OF LUNG CANCER
    李西平
    王洁
    王曾礼
    刘叙仪
    蒋薇
    Journal of Pharmaceutical Analysis, 2001, (01) : 53 - 55
  • [34] EGFR and c-erbB-2 expression in breast cancer progression
    Chong, D
    Reeves, J
    Cooke, T
    George, WD
    Mallon, E
    Ozanne, B
    Stanton, P
    BRITISH JOURNAL OF CANCER, 1998, 78 : 24 - 24
  • [35] C-ERBB-2 ONCOGENE EXPRESSION IN OVARIAN-CANCER
    HALDANE, JS
    HIRD, V
    HUGHES, CM
    GULLICK, WJ
    JOURNAL OF PATHOLOGY, 1990, 162 (03): : 231 - 237
  • [36] Overexpression of c-ErbB-2 protein in gastric cancer by immunohistochemical stain
    Lee, HR
    Kim, JH
    Uhm, HD
    Ahn, JB
    Rha, SY
    Cho, JY
    Lee, JI
    Lee, KH
    Chung, HC
    Roh, JK
    Min, JS
    Lee, KS
    Shin, DH
    Kim, BS
    Kim, BS
    Hong, SW
    Choi, JH
    ONCOLOGY, 1996, 53 (03) : 192 - 197
  • [37] c-erbB-2 oncoprotein content in gastric cancer and in adjacent mucosa
    García, I
    Vizoso, F
    Andicoechea, A
    Fernandez, P
    Suarez, C
    García-Muñiz, JL
    Allende, MT
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (03): : 231 - 234
  • [38] IMMUNOHISTOCHEMICAL STUDY OF C-ERBB-2 IN HUMAN GASTRIC-CANCER
    MIZUTANI, T
    ONDA, M
    OKUDA, T
    KIYAMA, T
    YOSHIYUKI, T
    SHIMIZU, Y
    NISHI, K
    MATSUKURA, N
    TOKUNAGA, A
    TANAKA, N
    YAMASHITA, K
    ASANO, G
    YAMANAKA, N
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (07) : 1067 - 1067
  • [39] Correlativity study on mammographic features and c-erbB-2 of breast cancer
    Jie Ma
    Oncology and Translational Medicine, 2006, (05) : 350 - 353
  • [40] C-ERBB-2 ONCOPROTEIN EXPRESSION AND AMPLIFICATION IN PLEOMORPHIC ADENOMA AND CARCINOMA EX PLEOMORPHIC ADENOMA - RELATIONSHIP TO PROGNOSIS
    MULLER, S
    VIGNESWARAN, N
    GANSLER, T
    GRAMLICH, T
    DEROSE, PB
    COHEN, C
    MODERN PATHOLOGY, 1994, 7 (06) : 628 - 632
12345